# Platelet Clumping and Pseudothrombocytopenia

## Quick Answer

- Platelet clumping is a common in vitro artifact that can cause automated analyzers to report falsely low platelet counts, leading to a misdiagnosis of thrombocytopenia.
- The first practical step when a low platelet count is reported is to review a stained blood smear to check for clumps before pursuing additional diagnostic tests.
- A key limitation is that clumping can occur even in properly collected samples, so smear review remains essential for confirming true versus artifactual thrombocytopenia.

## Understanding Platelet Clumping and Pseudothrombocytopenia

Platelet clumping, also known as platelet aggregation or agglutination, occurs when platelets adhere to each other in a blood sample. This phenomenon is a significant concern in veterinary clinical pathology because automated hematology analyzers count individual particles. When platelets clump together, the analyzer may not recognize the aggregate as multiple platelets, resulting in a falsely decreased platelet count. This condition is termed pseudothrombocytopenia because the actual platelet count in the animal is normal, but the laboratory result suggests a deficiency.

Pseudothrombocytopenia is an in vitro artifact, meaning it occurs after the blood sample is collected from the animal. It does not reflect a true disease state in the patient. The clinical importance of recognizing this artifact cannot be overstated. A misdiagnosis of thrombocytopenia can lead to unnecessary diagnostic testing, unwarranted treatments, and significant client concern. Conversely, failing to recognize true thrombocytopenia can delay appropriate care for conditions that cause bleeding disorders.

The phenomenon is well documented in veterinary medicine. Automated analyzers rely on impedance, optical, or fluorescence methods to count cells. Platelet clumps can be counted as white blood cells or simply excluded from the count, leading to errors. The magnitude of the error varies depending on the analyzer and the degree of clumping. In some cases, the reported platelet count may be severely low, prompting urgent intervention that is not needed.

## The Role of Blood Smear Review

Blood smear review is the cornerstone of confirming platelet clumping. A well-prepared and properly stained blood smear allows the examiner to visually assess platelet numbers and morphology. When clumping is present, the smear will show clusters of platelets, often at the feathered edge of the smear. The examiner can also estimate the platelet count per high-power field and compare it to the automated count.

The decision to perform a smear review should be triggered by any automated platelet count that is below the reference interval, or when the analyzer flags a platelet abnormality. Many laboratories have protocols that automatically trigger a smear review for low platelet counts. In practice, the smear review is a simple, cost-effective, and rapid procedure that can prevent a cascade of unnecessary diagnostic tests.

The smear also provides additional information beyond platelet clumping. It allows assessment of platelet morphology, including the presence of large platelets or macroplatelets, which can indicate increased platelet production. It also allows evaluation of other cell lines, such as red blood cells and white blood cells, which can provide clues to the underlying disease process. For example, the presence of schistocytes may suggest a microangiopathic process, while toxic changes in neutrophils may indicate sepsis.

## Automated Analyzer Limitations

Automated hematology analyzers are designed to count and size cells rapidly. However, they have inherent limitations when it comes to platelet counting. The primary limitation is the inability to distinguish between a single platelet and a clump of platelets. When a clump is encountered, the analyzer may either count it as one event or exclude it entirely, leading to a falsely low count.

Some analyzers have flags or alarms that indicate the presence of platelet clumps. These flags are based on the analyzer's internal algorithms and can be triggered by various patterns in the data. However, the sensitivity and specificity of these flags vary. A flag may not always be present, and the absence of a flag does not guarantee that clumping has not occurred. Therefore, the smear review remains the gold standard for confirming the presence of clumps.

Another limitation of automated analyzers is their inability to accurately count platelets when the platelet count is extremely low. In such cases, the analyzer may have difficulty distinguishing platelets from debris or other particles. This can lead to an overestimation or underestimation of the true count. The smear review can help to clarify the situation by providing a visual estimate of the platelet number.

## Sample Collection and Handling

The quality of the blood sample is a critical factor in preventing platelet clumping. The collection technique, the type of anticoagulant used, and the handling of the sample after collection can all influence the likelihood of clumping. The most common anticoagulant used for hematologic analysis is ethylenediaminetetraacetic acid, or EDTA. However, EDTA can induce platelet clumping in some animals, particularly in certain species.

The collection technique is also important. A clean, smooth venipuncture that minimizes tissue trauma is less likely to activate platelets and cause clumping. A difficult or prolonged collection can lead to platelet activation. The sample should be mixed gently with the anticoagulant, not shaken vigorously, to avoid activating platelets. The sample should be processed promptly, as delays can lead to clumping.

If clumping is observed in an EDTA sample, the laboratory may request a new sample collected in a different anticoagulant, such as sodium citrate. This is a common approach to confirm pseudothrombocytopenia. The citrate sample is used to obtain a more accurate platelet count. The laboratory should be notified of the suspected clumping so that the appropriate protocol can be followed.

## At a Glance

| Observation | Likely Interpretation | Recommended Action |
| --- | --- | --- |
| Automated platelet count low, clumps seen on smear | Pseudothrombocytopenia due to clumping | Report as clumping, consider citrate sample for accurate count |
| Automated platelet count low, no clumps on smear | True thrombocytopenia | Investigate underlying cause, consider further diagnostics |
| Automated platelet count low, clumps seen on smear, but also clinical bleeding | Possible true thrombocytopenia with concurrent clumping | Urgent evaluation, consider additional testing and treatment |

## Species-Specific Considerations

Platelet clumping is more common in some species than in others. Cats are particularly prone to platelet clumping, and this is a well-recognized phenomenon in feline medicine. The reason for this is not fully understood, but it is a common cause of pseudothrombocytopenia in cats. The use of alternative anticoagulants, such as sodium citrate, is often necessary to obtain an accurate platelet count in cats.

Dogs can also experience platelet clumping, but it is generally less common than in cats. The degree of clumping can vary between individual animals. Some dogs may have a tendency to clump, and this can be a consistent finding across multiple samples. The laboratory should be aware of this tendency and may recommend a specific protocol for these patients.

Other species, such as horses and ruminants, may also exhibit platelet clumping. The clinical significance is similar, and the approach to diagnosis is the same. The smear review is the key step in all species. The laboratory should be familiar with the normal platelet morphology for each species to accurately assess the smear.

## Diagnostic Workflow

The diagnostic workflow for a low platelet count should be systematic. The first step is to confirm the result with a blood smear review. The smear should be examined for the presence of clumps, and the platelet count should be estimated. If clumps are present, the result is likely a pseudothrombocytopenia, and the true platelet count may be normal.

If the smear review does not show clumps, the low platelet count is likely real. The next step is to determine the underlying cause. This may involve a thorough history and physical examination, as well as additional diagnostic tests. The tests may include a complete blood count with a manual differential, a chemistry panel, and a coagulation profile. The specific tests will depend on the clinical signs and the suspected underlying disease.

The workflow should also include a consideration of the animal's clinical status. If the animal is bleeding or has signs of a bleeding disorder, the situation is urgent, and the animal should be evaluated immediately. If the animal is not bleeding, the situation may be less urgent, but the underlying cause should still be investigated. The decision to escalate to a specialist or an emergency facility should be based on the clinical status and the severity of the thrombocytopenia.

## Mermaid Flowchart

```mermaid
flowchart TD
    A[Automated platelet count low] --> B{Review blood smear}
    B -->|Clumps present| C[Pseudothrombocytopenia]
    B -->|No clumps| D[True thrombocytopenia]
    C --> E[Confirm with citrate sample if needed]
    D --> F[Investigate underlying cause]
    F --> G[History and physical exam]
    F --> H[Additional diagnostic tests]
    G --> I[Clinical management]
    H --> I
```

## Practical Implementation Steps

The following steps provide a practical approach to managing a low platelet count in a veterinary setting. These steps are designed to be implemented in a clinical laboratory or a veterinary practice.

1.  **Review the automated result.** When a platelet count is below the reference interval, the result should be flagged for review. The laboratory should have a protocol for this situation.
2.  **Prepare a blood smear.** A well-made smear is essential. The smear should be made from a fresh sample and stained with a standard stain, such as Wright-Giemsa.
3.  **Examine the smear.** The examiner should scan the smear, particularly the feathered edge, for platelet clumps. The platelet count should be estimated by counting the number of platelets per high-power field.
4.  **Compare the estimates.** The estimated count from the smear should be compared to the automated count. If the smear estimate is significantly higher, clumping is likely.
5.  **Confirm with a citrate sample.** If clumping is suspected, a new sample should be collected in sodium citrate. The platelet count from the citrate sample should be more accurate.
6.  **Document the findings.** The laboratory should document the presence of clumping and the estimated platelet count. This information is important for the clinician.
7.  **Communicate with the clinician.** The laboratory should communicate the findings to the clinician, including the suspicion of pseudothrombocytopenia. This will help the clinician make informed decisions.

## Records and Measurements

Accurate records are essential for managing platelet clumping and pseudothrombocytopenia. The laboratory should maintain a log of all samples with low platelet counts, including the automated count, the smear estimate, and the presence or absence of clumps. This log can be used to identify trends and to assess the frequency of clumping in the practice.

The records should also include the type of anticoagulant used, the time between collection and analysis, and any flags from the analyzer. This information can help to identify the cause of clumping and to prevent it in the future. The records should be reviewed periodically to ensure that the protocols are effective.

The measurements should be standardized. The smear estimate should be performed in a consistent manner, and the number of high-power fields examined should be recorded. The use of a standardized protocol will improve the reliability of the results. The records should also include the clinical status of the animal, as this is important for interpreting the results.

## Common Failure Patterns

Several common failure patterns can occur in the management of platelet clumping. One pattern is the failure to review a smear when the automated count is low. This can lead to a misdiagnosis of thrombocytopenia and unnecessary interventions. The laboratory should have a protocol that ensures a smear is reviewed for all low platelet counts.

Another failure pattern is the failure to recognize the limitations of the automated analyzer. The analyzer may not always flag the presence of clumps, and the absence of a flag does not rule out clumping. The laboratory should be aware of this limitation and should not rely solely on the analyzer's flags.

A third failure pattern is the failure to confirm the result with a citrate sample. If clumping is suspected, a citrate sample should be collected to obtain an accurate count. Failure to do so can lead to a persistent misdiagnosis. The laboratory should have a protocol for collecting and processing citrate samples.

## Welfare and Safety Context

The welfare of the animal is a primary concern in any diagnostic procedure. The collection of a blood sample is a routine procedure, but it should be performed with care to minimize stress and pain. The use of a proper technique and a clean, sharp needle can reduce the risk of complications.

The safety of the laboratory personnel is also important. The handling of blood samples carries a risk of exposure to infectious agents. The laboratory should follow standard safety protocols, including the use of gloves and other personal protective equipment. The disposal of needles and other sharps should be done in a safe manner.

The welfare of the animal is also a concern when a misdiagnosis occurs. A false diagnosis of thrombocytopenia can lead to unnecessary treatments, which can be stressful and potentially harmful. A false diagnosis of a normal platelet count can delay treatment for a bleeding disorder. The accurate diagnosis of platelet clumping is therefore important for the welfare of the animal.

## Professional Escalation Criteria

The decision to escalate a case to a veterinarian or a specialist should be based on the clinical status of the animal and the severity of the findings. The following criteria should be considered.

- **Urgent escalation:** If the animal is bleeding, has signs of a bleeding disorder, or is clinically unstable, the case should be escalated immediately. This is a medical emergency.
- **Routine escalation:** If the animal is not bleeding and is clinically stable, the case can be escalated on a routine basis. The veterinarian can then decide on the next steps.
- **Specialist referral:** If the underlying cause of the thrombocytopenia is unclear, or if the case is complex, the veterinarian may refer the animal to a specialist, such as a veterinary internal medicine specialist or a clinical pathologist.

The laboratory should also have a protocol for escalating abnormal results. The protocol should define the criteria for calling the veterinarian and the information that should be provided. The protocol should also define the criteria for recommending a citrate sample.

## Building a Practice-Level Platelet Clumping Protocol

A recurring problem in veterinary practice is not the absence of knowledge about platelet clumping but the absence of a structured protocol that turns that knowledge into consistent action. When every clinician and technician handles low platelet counts differently, the result is variable diagnostic quality, missed clumps, and unnecessary client anxiety. A written protocol standardizes the response to a low automated platelet count, defines who does what, and creates a record that can be audited for quality. This section provides a practical decision framework that any practice can adapt, with specific triggers, actions, and documentation requirements.

### The Three-Tier Decision Framework

The framework below organizes the response to a low platelet count into three tiers based on the clinical status of the patient and the laboratory findings. Each tier has a distinct set of actions and a clear endpoint. The framework assumes that the automated analyzer has reported a platelet count below the laboratory reference interval or has flagged a platelet abnormality.

**Tier 1: Stable Patient with No Bleeding Signs**

This is the most common scenario. The patient presents for a routine wellness examination, a pre-surgical screen, or an unrelated illness. The automated platelet count is low, but the patient shows no clinical signs of bleeding, such as petechiae, ecchymoses, melena, hematuria, or prolonged bleeding from venipuncture sites.

The first action is a blood smear review. The smear must be examined for platelet clumps, with particular attention to the feathered edge where clumps tend to accumulate. If clumps are present, the result is reported as pseudothrombocytopenia. The clinician should be notified, and a repeat sample in sodium citrate should be considered if an accurate platelet count is needed for clinical decisions, such as before surgery.

If no clumps are seen on the smear and the platelet estimate is low, the result is reported as true thrombocytopenia. The clinician should then investigate the underlying cause. This investigation may include a thorough history, physical examination, and additional diagnostic tests such as a chemistry panel, coagulation profile, or infectious disease testing. The urgency of this investigation depends on the severity of the thrombocytopenia and the patient's overall clinical picture.

**Tier 2: Stable Patient with a History of Clumping**

Some patients have a documented tendency to platelet clumping. This may be a consistent finding across multiple samples, or it may be a known species-related issue, particularly in cats. For these patients, the protocol should include a standing order to collect blood in both EDTA and sodium citrate tubes at the time of the initial venipuncture.

This approach avoids the need for a second blood collection and reduces the delay in obtaining an accurate platelet count. The EDTA sample is used for the complete blood count and smear review. The citrate sample is held in reserve and processed for platelet count if clumping is confirmed on the smear. This practice is efficient and reduces the number of venipunctures, which is a welfare consideration for the patient.

The practice should maintain a list of patients with a known clumping tendency. This list can be a simple spreadsheet or a note in the practice management software. When a patient on this list presents for a blood draw, the technician or veterinarian is alerted to collect both tubes from the start.

**Tier 3: Unstable Patient or Patient with Bleeding Signs**

This is the emergency scenario. The patient has clinical signs of bleeding, such as petechiae, ecchymoses, melena, hematuria, or bleeding from the nose or gums. The automated platelet count is low, and the patient is clinically unstable.

In this situation, the blood smear review is still performed, but it is done concurrently with the initial assessment and stabilization. The presence of clumps on the smear does not rule out true thrombocytopenia. The patient may have both clumping and a genuinely low platelet count. The smear review provides an estimate of the platelet number, but the clinical picture takes priority.

The patient should be evaluated immediately by the veterinarian. Additional diagnostic tests, such as a coagulation profile, may be indicated. The patient may require treatment, including platelet support or blood products, depending on the severity of the bleeding and the underlying cause. The decision to refer to an emergency facility or a specialist should be made based on the patient's stability and the practice's capabilities.

### The Clump Confirmation Checklist

The following checklist is a practical tool for the technician or veterinarian performing the smear review. It ensures that the examination is systematic and that no key steps are missed.

1.  **Confirm the sample identity.** Verify that the smear matches the patient and the sample that produced the automated count.
2.  **Scan the feathered edge.** Examine the feathered edge of the smear at low power for platelet clumps. Clumps are often found here because the larger aggregates are carried to the end of the smear.
3.  **Examine the monolayer.** Move to the monolayer, where cells are in a single layer, and assess the platelet distribution. Platelets should be evenly distributed in a healthy sample.
4.  **Estimate the platelet count.** Count the number of platelets in several high-power fields and calculate an average. A general rule is that one platelet per high-power field corresponds to approximately 15,000 to 20,000 platelets per microliter, but this varies with the microscope and the field size. The practice should establish its own conversion factor.
5.  **Look for clumps of varying sizes.** Clumps can be small, with only a few platelets, or large, with dozens of platelets. The presence of any clumps should be noted.
6.  **Assess platelet morphology.** Note the presence of large platelets, which can indicate increased platelet production. This finding can help distinguish between a regenerative and a non-regenerative thrombocytopenia.
7.  **Document the findings.** Record the presence or absence of clumps, the estimated platelet count, and any morphological abnormalities. This documentation is essential for the medical record and for communication with the clinician.

### The Citrate Sample Protocol

When a citrate sample is needed, the protocol should be clear to avoid errors. The citrate tube contains a liquid anticoagulant, so the tube must be filled to the correct volume to maintain the proper ratio of blood to anticoagulant. An underfilled or overfilled tube can affect the accuracy of the platelet count.

The protocol should specify the following steps:

1.  **Collect the sample.** Use a clean venipuncture and fill the citrate tube to the marked line.
2.  **Mix gently.** Invert the tube gently several times to mix the blood with the citrate. Do not shake the tube.
3.  **Label the tube.** Label the tube with the patient ID, the date, and the time of collection.
4.  **Process promptly.** The sample should be processed as soon as possible to avoid platelet activation and clumping.
5.  **Note the dilution factor.** The platelet count from a citrate sample must be corrected for the dilution by the citrate. The correction factor is typically 1.1, but this depends on the specific tube and the protocol. The laboratory should have a standard correction factor and apply it consistently.

The citrate sample is not a substitute for the EDTA sample. It is a supplementary sample used to obtain an accurate platelet count when clumping is a problem. The EDTA sample is still used for the other components of the complete blood count.

### The Clumping Log and Trend Analysis

A clumping log is a simple but powerful tool for quality improvement. The log records every case where platelet clumping is identified. The log should include the patient ID, the species, the date, the automated platelet count, the smear estimate, the presence or absence of clumps, and the action taken, such as a citrate sample.

The log can be used to identify trends. For example, the practice may notice that clumping is more common in certain species, such as cats, or in samples collected by certain technicians. This information can be used to adjust the collection technique or to provide additional training. The log can also be used to track the frequency of clumping over time and to assess the effectiveness of the protocol.

The log should be reviewed periodically, such as monthly or quarterly. The review should include a discussion of any cases where the protocol was not followed and any cases where the outcome was unexpected. This review is an opportunity for the team to learn and to improve the protocol.

### Troubleshooting the Persistent Clumper

Some patients consistently produce clumped samples, even when the collection technique is optimal. For these patients, the protocol should include a specific troubleshooting pathway.

The first step is to confirm that the collection technique is correct. A clean, smooth venipuncture is essential. The needle should be the appropriate size for the patient, and the blood should flow freely. A difficult collection can activate platelets and cause clumping.

The second step is to consider the anticoagulant. If the patient clumps in EDTA, a citrate sample should be collected. If the patient also clumps in citrate, the clumping may be a persistent in vitro phenomenon. In this case, the platelet count may need to be estimated from the smear, and the clinician should be informed of the limitation.

The third step is to consider the timing. The sample should be processed promptly. A delay between collection and analysis can increase the likelihood of clumping. The sample should be kept at room temperature and not refrigerated, as cold can also activate platelets.

The fourth step is to consider the analyzer. Some analyzers are more prone to clumping artifacts than others. The laboratory should be aware of the limitations of its analyzer and should have a protocol for verifying low platelet counts.

### The Communication Protocol

Clear communication between the laboratory and the clinician is essential. The laboratory should have a protocol for reporting low platelet counts and for flagging the presence of clumping. The protocol should define the following:

- **The initial report.** The automated platelet count is reported with a flag indicating that a smear review is needed.
- **The smear review result.** The smear review result is reported, including the presence or absence of clumps and the estimated platelet count.
- **The final report.** The final report includes the automated count, the smear estimate, and the interpretation, such as pseudothrombocytopenia or true thrombocytopenia.
- **The clinician notification.** The laboratory should notify the clinician when the result is critical or when the interpretation is uncertain.

The communication should be clear and concise. The clinician needs to know whether the platelet count is reliable and what the next steps should be. The communication should also include the recommendation for a citrate sample when clumping is present.

### The Record System for Platelet Clumping

The record system for platelet clumping should be integrated into the practice management system. The record should include the following:

- The patient ID and species
- The date and time of collection
- The type of anticoagulant used
- The automated platelet count
- The smear review result, including the presence or absence of clumps
- The estimated platelet count from the smear
- The final interpretation
- The action taken, such as a citrate sample or a referral

The record should be accessible to the clinician and the laboratory staff. It should be reviewed as part of the patient's medical record and used for future decisions. For example, if a patient has a history of clumping, the clinician can order both EDTA and citrate tubes for future blood draws.

### The Escalation Criteria for the Protocol

The protocol should include clear escalation criteria. The following criteria should trigger an immediate call to the clinician:

- The patient has clinical signs of bleeding.
- The automated platelet count is critically low, such as below 20,000 platelets per microliter.
- The smear review shows no clumps and the estimated platelet count is low.
- The smear review shows clumps, but the patient is clinically unstable.

The escalation criteria should be defined in the protocol and should be known to all staff. The goal is to ensure that the patient receives the appropriate care in a timely manner.

### The Training and Competency Plan

The protocol is only as effective as the staff who implement it. The practice should have a training plan for all staff involved in blood collection and analysis. The training should cover the following:

- The proper technique for blood collection
- The proper handling of samples
- The preparation and staining of blood smears
- The identification of platelet clumps
- The estimation of platelet counts from smears
- The use of the clumping log
- The escalation criteria

The training should be documented and repeated periodically. The staff should be assessed for competency, and the assessment should be recorded. The training plan should be reviewed and updated as needed.

### The Practice-Level Quality Check

The practice should conduct a periodic quality check of its platelet clumping protocol. The quality check should include the following:

- A review of the clumping log to identify trends
- A review of the cases where the protocol was not followed
- A review of the cases where the result was unexpected
- A discussion of the lessons learned
- An update to the protocol as needed

The quality check should be conducted at least quarterly. The results should be documented and used to improve the protocol. The quality check is an opportunity for the team to learn and to improve the care of the patients.

### The Role of the Veterinarian in the Protocol

The veterinarian has a central role in the protocol. The veterinarian is responsible for the interpretation of the results and for the clinical decisions. The veterinarian should be informed of the findings and should be involved in the escalation of the cases. The veterinarian should also be responsible for the training of the staff and for the review of the protocol.

The veterinarian should also be aware of the limitations of the automated analyzer and the smear review. The veterinarian should use the information from the protocol to make informed decisions about the patient's care. The veterinarian should also be aware of the potential for the clumping to be a persistent phenomenon in some patients and should plan accordingly.

### The Protocol in the Context of the Practice

The protocol should be integrated into the practice's standard operating procedures. It should be available to all staff and should be reviewed periodically. The protocol should be updated as the practice grows and as new equipment is introduced. The protocol should be a living document that reflects the best practices of the practice.

The protocol should also be aligned with the practice's quality standards. The practice should have a commitment to the accurate diagnosis and the appropriate care of the patients. The protocol is a tool for achieving this commitment. The protocol should be used consistently and should be the basis for the management of the low platelet count.

### The Protocol and the Client Communication

The protocol should also include a plan for the client communication. When a low platelet count is reported, the client should be informed of the findings and the next steps. The client should be told that the low count may be due to the clumping, which is a laboratory artifact, and that a repeat sample may be needed. The client should be reassured that the clumping is not a disease and that the true platelet count may be normal.

The client communication should be clear and compassionate. The client should be given the information they need to make informed decisions about the care of their pet. The client should also be told when to seek immediate care, such as if the pet shows signs of bleeding. The client communication is an important part of the overall care of the patient.

### The Protocol and the Future

The protocol should be designed to be adaptable. As new research and new technologies become available, the protocol should be updated. The practice should stay informed of the latest developments in the field of veterinary hematology. The protocol should be a tool for the continuous improvement of the care of the patients.

The protocol should also be a tool for the education of the staff and the clients. The protocol should be used to teach the staff about the importance of the blood smear review and the limitations of the automated analyzer. The protocol should be used to teach the clients about the importance of the diagnostic testing and the management of the low platelet count.

The protocol is a practical tool for the practice. It is a way to ensure that the low platelet count is managed in a consistent and effective manner. The protocol is a way to prevent the misdiagnosis of the thrombocytopenia and to ensure that the patient receives the appropriate care. The protocol is a way to improve the quality of the care and the welfare of the patient.

## Frequently Asked Questions

### What is the most common cause of a false low platelet count in veterinary medicine?

The most common cause is platelet clumping, which is an in vitro artifact. The clumps are not counted by the automated analyzer, leading to a falsely low result. This is particularly common in cats.

### How can I tell if a low platelet count is real or an artifact?

The best way is to review a blood smear. If clumps are present, the low count is likely an artifact. If no clumps are present, the count is likely real.

### What is the best anticoagulant to use for a platelet count?

EDTA is the standard anticoagulant for a complete blood count. However, if clumping is a problem, a sample collected in sodium citrate can be used to obtain a more accurate platelet count.

### Can platelet clumping be prevented?

In some cases, yes. A clean, smooth venipuncture and gentle mixing of the sample can reduce the risk. However, some animals have a tendency to clump, and this may not be preventable.

### What should I do if the analyzer flags a low platelet count?

The first step is to review a blood smear. The smear should be examined for the presence of clumps. If clumps are present, the result is likely a pseudothrombocytopenia.

### Is pseudothrombocytopenia a dangerous condition?

No, pseudothrombocytopenia is not a dangerous condition. It is a laboratory artifact. The animal's true platelet count is normal. The danger is in the misdiagnosis, which can lead to unnecessary tests and treatments.

### What is the difference between platelet clumping and platelet aggregation?

The terms are often used interchangeably. Platelet clumping is a general term for the adherence of platelets to each other. Platelet aggregation is a more specific term that can refer to the process of activation and adhesion. In the context of a blood sample, they both refer to the same phenomenon.

### When should I seek immediate veterinary care for a low platelet count?

Immediate veterinary care is needed if the animal is bleeding, has signs of a bleeding disorder, or is clinically unstable. This includes signs such as bruising, blood in the urine or stool, or bleeding from the nose or gums.

## Using the Evidence

| Source | Best use in this topic | Important limitation |
|---|---|---|
| [Pet Care](https://www.avma.org/resources-tools/pet-owners) | official guidance | Check the linked page for current local requirements |
| [AAHA Guidelines](https://www.aaha.org/resources) | official guidance | Check the linked page for current local requirements |
| [Global Guidelines](https://wsava.org/global-guidelines) | official guidance | Check the linked page for current local requirements |

## Related Veterinary Guides

- [Measuring Agreement in Veterinary Diagnostic Tests](/knowledge/veterinary-medicine/veterinary-research-methods/measuring-agreement-veterinary-diagnostic-tests)
- [Interpreting the Canine CBC: A Diagnostic Approach](/knowledge/veterinary-medicine/clinical-pathology/interpreting-canine-cbc-diagnostic-approach)
- [Common Diagnostic Errors in NAVLE Preparation and How to Avoid Them](/knowledge/veterinary-medicine/navle-exam-prep/common-diagnostic-errors-in-navle-preparation-and-how-to-avoid-them)
- [Cytology of the Liver and Spleen: Diagnostic Utility and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/cytology-liver-spleen-veterinary)
- [Veterinary Thrombocytopenia: Confirmation, Bleeding Risk, and Diagnostic Workup](/knowledge/veterinary-medicine/clinical-methods/veterinary-thrombocytopenia-confirmation-bleeding-risk-diagnostic-workup)

## References and Further Reading

- [Pet Care](https://www.avma.org/resources-tools/pet-owners). American Veterinary Medical Association.
- [AAHA Guidelines](https://www.aaha.org/resources). American Animal Hospital Association.
- [Global Guidelines](https://wsava.org/global-guidelines). World Small Animal Veterinary Association.
- [Merck Veterinary Manual](https://www.merckvetmanual.com/). Merck Veterinary Manual.
- [Cornell University College of Veterinary Medicine](https://www.vet.cornell.edu/). Cornell University.
- [Animal Health and Welfare](https://www.woah.org/en/what-we-do/animal-health-and-welfare). World Organisation for Animal Health.
- [Kanamycin treated-ethylenediamine tetraacetic acid-dependent pseudothrombocytopenia in blood specimen of cats.](https://pubmed.ncbi.nlm.nih.gov/38938430). Open veterinary journal, 2024.
- [Amikacin prevents platelet aggregation in feline venous blood samples.](https://pubmed.ncbi.nlm.nih.gov/35141933). Veterinary clinical pathology, 2022.
- [Utility of immature platelet fraction in the Sysmex XN-1000V for the differential diagnosis of central and peripheral thrombocytopenia in dogs and cats.](https://pubmed.ncbi.nlm.nih.gov/38619127). Journal of veterinary internal medicine, 2024.
- [Amikacin disaggregates platelet clumps in EDTA blood samples from cats and dogs when added postcollection.](https://pubmed.ncbi.nlm.nih.gov/36849708). Veterinary clinical pathology, 2023.
- [Effect of prewarming EDTA blood samples to 37°C on platelet count measured by Sysmex XT-2000iV in dogs, cats, and horses.](https://pubmed.ncbi.nlm.nih.gov/27391303). Veterinary clinical pathology, 2016.

> This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.